More than 40 percent of older patients with acute myeloid leukemia (AML) can remain in long-term cancer remission through a modified, less aggressive approach to donor stem cell transplantation, according to the results of a phase 2 study.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1PdYu8P
No comments:
Post a Comment